- Sector: Healthcare
- Industry: Biotechnology
- Founded in 2011
- Headquartered in South San Francisco, California
- http://www.gbt.com
Wednesday, August 12, 2015
Global Blood Therapeutics (GBT) began trading on the Nasdaq on 12 Aug 2015
Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing therapeutics to treat blood-based disorders. The Company is developing its initial product candidate, GBT440, as an oral, once-daily therapy for sickle cell disease (SCD).
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment